Skip to main content

Dupilumab improves both histaminergic and touch?evoked itch sensitization (hyperknesis) in atopic dermatitis: A pilot study

Meer van Journal of the European Academy of Dermatology and Venereology
Home

Dermatologieportal

Gerelateerd

  • Two indurated bullous plaques on the upper back of an adult
  • Case report: SARS?CoV?2 induced urticaria or just a concomitance?
  • Morphological evolution in melanoma in situ using revised pattern analysis

Tags

Trending

  • Psoriasis and progression of Parkinson's disease: a Mendelian randomization study
  • Quality of life impact and treatment response in vulval disease: Comparison of 3 common conditions using the Vulval Quality of Life Index
  • The impact of hidradenitis suppurativa on quality of life is worse than inflammatory bowel disease and myocardial infarction
  • Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune?mediated dermatological conditions
  • Development of the Cold Urticaria Activity Score
  • A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes

Log in met Medi-Access

Wilt u het gehele artikel lezen?
Log in met Medi-Access om verder te lezen

Login Registreren

Dupilumab improves both histaminergic and touch?evoked itch sensitization (hyperknesis) in atopic dermatitis: A pilot study

Journal of the European Academy of Dermatology and Venereology | Geplaatst op 23.06.2022 18:16